$RVII

Robinhood Ventures Fund II (RVII) prices at $25, raising $200 million

Robinhood Ventures Fund II (RVII) priced its shares at $25 each to raise $200 million, according to the fund. The NYSE-listed structure is designed to let retail investors trade exposure to late-stage private companies without accredited-investor restrictions. Goldman Sachs, Citigroup, J.P. Morgan, UBS, and Wells Fargo underwrote the deal.

Original reporting
Published Aug 13, 2026, 10:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 10:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Robinhood Ventures Fund II (RVII) prices at $25, raising $200 million — source image
Decision brief

The 30-second read

$RVIIBullishMed
01

Why it matters

For traders, the actionable element is the new offering price ($25) and capital raised ($200 million), which can affect short-term flows and valuation expectations until more portfolio and NAV details emerge.

02

Market read

A newly priced, NYSE-listed private-market exposure fund can attract retail and brokerage-driven flows, with near-term trading centered on the $25 offering reference and future NAV/holdings disclosures.

03

What to watch

Key missing details include the fund’s target portfolio, fee structure, redemption/lock-up mechanics for underlying assets, and how quickly NAV will be published relative to trading.

Relevance 6/10Novelty 7/10Timing: priced and raised $200 million at $25, likely immediately relevant for today’s trading

Background

The article frames RVII as a second Robinhood-linked vehicle that brings retail investors into late-stage private-company exposure that was previously limited to accredited investors.

Company-level read

Ticker impact

$RVIIBullishMedium confidence
Context

RVII priced shares at $25 and raised $200 million, expanding retail access to late-stage private-company exposure via NYSE listing.

Expected impact

Likely near-term volatility around the $25 reference price as investors price liquidity and expectations for the underlying private holdings.

Evidence & confidence

This is a primary disclosure of the offering price and size, but the article provides no details on the portfolio composition, fees, or expected timeline to NAV updates.

Market effects

Highlights continued productization of private-market exposure into exchange-traded structures, which may spur competitive offerings in alternative investment wrappers.

Primarily US-focused via NYSE listing and retail brokerage access.

Limited direct global impact, though it reflects a broader trend in private-market democratization.

Counterpoint

The $200 million raise may not translate into sustained performance if the underlying private holdings underperform or if fees and liquidity differ from investor expectations.

Key entities

  • Robinhood Ventures Fund II

    NYSE-listed vehicle that priced at $25 per share to raise $200 million.

  • Goldman Sachs

    One of the bookrunners in the syndicate underwriting the deal.

  • Citigroup

    One of the bookrunners in the syndicate underwriting the deal.

  • J.P. Morgan

    One of the bookrunners in the syndicate underwriting the deal.

  • UBS

    One of the bookrunners in the syndicate underwriting the deal.

Related articles

$RVIIMed

Robinhood’s Second Venture BDC Lists at a Discount, Testing Retail Access to Early-Stage Private Markets:

Robinhood Ventures Fund II (BDC) priced 8 million shares at $25, raising a $225.5 million fund size, or $255.5 million if underwriters exercise an option, and began trading on the NYSE as RVII. Shares opened at $22.50, about 10% below IPO price. The 1940 Act BDC is advised by a Robinhood Markets subsidiary and targets early-stage private companies, including YC-linked firms.

$BETRMed

Garg claims majority backing in bid to reclaim Better's board

Vishal Garg, ousted founder of Better Home & Finance Holding Co, said Aug. 13 he secured signed shareholder declarations representing a majority of voting power to seek board reconstitution and control. He demanded directors resign or face a special meeting. Better shares fell to about $15 after his bid. Better reported revenue and loan volume growth, while the board cited losses and alleged securities-law issues.

$BETRMed

Better pushes back on Garg's bid to regain control

Better (Better Home) says founder Vishal Garg is seeking to regain control by asking five directors to resign, offering to work for $1 and repurchase $30 million of stock. The board disputes this, citing alleged refusal to sign 10-Q representation letters and potential securities law violations. Better reports Q2 2026 adjusted EBITDA loss of $14M and 11 straight quarters of losses.

$HSBCMedAI 8/10

Issuance of senior unsecured notes

HSBC Holdings plc said it issued US$2.5 billion 5.243% fixed rate, floating rate senior unsecured notes due 2032, US$3.25 billion 5.729% fixed rate, floating rate notes due 2037, and US$1.0 billion floating rate notes due 2032. The notes were listed on the NYSE and issued under an indenture dated 26 Aug 2009, as amended.